Clinical Trials Browser

Phase 1 × Squamous Cell Carcinoma of Head and Neck × Immune Checkpoint Inhibitors × Clear all

NCT04290546 2026-02-27

CIML NK Cell in Head & Neck Cancer

Phase 1 Completed

Squamous Cell Carcinoma of Head and Neck

NCT04417465 2025-09-25

First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic Tumors

Phase 1 Completed

Squamous Cell Carcinoma of Head and Neck, Neoplasms